Gene · 8900
Papers2,123
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,123
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological Potential of Carnivorous Plants from Nepenthales. | Molecules | 2023 | 37110873 | PubTator, text mining | PubMed |
| TRPM2 regulates cell cycle through the Ca2+-CaM-CaMKII signaling pathway to promote HCC. | Hepatol Commun | 2023 | 37058100 | PubTator, text mining | PubMed |
| Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37046721 | PubTator, text mining | PubMed |
| PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer. | Front Immunol | 2023 | 37026005 | PubTator, text mining | PubMed |
| 1,6-Hexanediol regulates angiogenesis via suppression of cyclin A1-mediated endothelial function. | BMC Biol | 2023 | 37024934 | PubTator, text mining | PubMed |
| Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours. | Br J Cancer | 2023 | 37024667 | PubTator, text mining | PubMed |
| A novel long noncoding RNA AC125257.1 facilitates colorectal cancer progression by targeting miR-133a-3p/CASC5 axis. | Open Med (Wars) | 2023 | 37009050 | PubTator, text mining | PubMed |
| NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis. | Aging (Albany NY) | 2023 | 36996493 | PubTator, text mining | PubMed |
| Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts-A Systematic Review. | Cancers (Basel) | 2023 | 36980718 | PubTator, text mining | PubMed |
| CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma. | BMC Cancer | 2023 | 36959566 | PubTator, text mining | PubMed |
| Histone demethylase KDM4B contributes to advanced clear cell renal carcinoma and association with copy number variations and cell cycle progression. | Epigenetics | 2023 | 36952476 | PubTator, text mining | PubMed |
| Integrated analysis of Dendrobium nobile extract Dendrobin A against pancreatic ductal adenocarcinoma based on network pharmacology, bioinformatics, and validation experiments. | Front Pharmacol | 2023 | 36937875 | PubTator, text mining | PubMed |
| Methylation Profile of Cancer Testis Antigens in Colorectal Cancer. | Iran J Immunol | 2023 | 36932973 | PubTator, text mining | PubMed |
| GEMC1 and MCIDAS interactions with SWI/SNF complexes regulate the multiciliated cell-specific transcriptional program. | Cell Death Dis | 2023 | 36932059 | PubTator, text mining | PubMed |
| Separase and Roads to Disengage Sister Chromatids during Anaphase. | Int J Mol Sci | 2023 | 36902034 | PubTator, text mining | PubMed |
| Association between small nucleolar RNA host gene expression and survival outcome of colorectal cancer patients: A meta-analysis based on PRISMA and bioinformatics analysis. | Front Oncol | 2023 | 36895488 | PubTator, text mining | PubMed |
| SPHINX-Based Combination Therapy as a Potential Novel Treatment Strategy for Acute Myeloid Leukaemia. | Br J Biomed Sci | 2023 | 36895328 | PubTator, text mining | PubMed |
| Non-canonical functions of SNAIL drive context-specific cancer progression. | Nat Commun | 2023 | 36882420 | PubTator, text mining | PubMed |
| Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency. | Cell Commun Signal | 2023 | 36869329 | PubTator, text mining | PubMed |
| Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma. | J Cancer | 2023 | 36860920 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8900/papers?page=10